Diabetes: What patients want

It is a well-known fact that the prevalence of type 2 diabetes (T2DM) is increasing worldwide. According to the International…

Read More
CPD POINTS: 2

Do fixed-ratio combinations herald the end of basal insulin alone in T2DM?

In their study investigating different strategies to initiate and intensify basal insulin treatment in patients with type 2 diabetes (T2DM),…

Read More
CPD POINTS: 2

Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Delving deeper

GLP-1 RA studies showed a macrovascular disease benefit.

Read More
CPD POINTS: 1

REWINDING REWARD in the management of type 2 diabetes

SGLT2-inhibitors have a major beneficial effect on reducing heart failure

Read More
CPD POINTS: 1

Combining for effective simplicity

In this article we will look at key lessons learned from landmark studies.

Read More
CPD POINTS: 1

Specialist Forum October 2021 issue CPDs

Below you will find links to CPD articles produced for Specialist Forum‘s October 2021 issue.

Read More
CPD POINTS: 3

Superior HbA1c reduction with Solimix

Type 2 diabetes (T2DM) is a progressive disease, associated with microvascular complications such as retinopathy, nephropathy, and neuropathy, as well…

Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus

Dr Nqoba Tsabedze, Academic & Clinical Head – Division of Cardiology, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand 

Read More
CPD POINTS: 1

Controlling blood sugar levels optimally

Type 2 diabetes (T2DM) is a major global public health problem. According to the World Health Organisation, about 422 million…

Empagliflozin and metformin to reduce cardiac risk in type 2 diabetes?

Type 2 diabetes is a major risk factor for cardiovascular disease. Having both type 2 diabetes and cardiovascular disease increases…

The challenge of diabetes management in LMICs

In low-and middle-income countries, especially in Sub-Saharan Africa, noncommunicable diseases (NCDs) such as diabetes are placing a growing strain on…

Read More
CPD POINTS: 1

Achieving optimal glycaemic control with insulin lispro pens

A rise in body weight or worsening insulin tolerance in diabetic patients nearly always results in an increase in their…

Read More
CPD POINTS: 1

New hope for obesity patients

Liraglutide, which has consistently shown 5%-10% of weight-loss when combined with diet and physical activity, has been given the go-ahead…

Read More
CPD POINTS: 3